Postpartum Depression Management Market Outlook (2022 to 2032)
The global postpartum depression management market is poised to register a 3.8% CAGR, capturing a revenue share of US$ 115.1 million in 2022, to reach US$ 173.9 million by 2032.
In pregnancy and childbirth, there is an acute case of clinical depression that is called postpartum depression. It is a very common mood disorder examined specifically in pregnant mothers, though it affects both men and women.
As per a study published in a peer-reviewed journal, 1 out of 7 women who gave birth to a newborn suffered from postpartum depression. After three weeks of giving birth to a newborn, a mother starts feeling the effects of depression.
Postpartum depression management market growth is attributed to various factors that affect postpartum depression rates after pregnancy. These risk factors include hormonal and physical changes, a history of depression and stress, emotional imbalance, and bipolar disorder.
In pregnancy, mental disorders and mood swings are driving growth in the postpartum depression management market. Some of the major symptoms of postpartum depression among women include hopelessness, sadness, learning and memorizing, inability to focus, anxiety and exhaustion, loss of interest in self-care, and appetite problems.
Report Attribute
Details
Postpartum Depression Management Market Value (2022)
US$ 115.1 Million
Postpartum Depression Management Market Anticipated Forecast Value (2032)
US$ 173.9 Million
Postpartum Depression Management Market Projected Growth Rate (2022 to 2032)
3.8%
To achieve better results, getting diagnosed by a doctor is crucial. Antidepressant prescriptions include Bupropion, Amitriptyline, Trimipramine, Fluoxetine, Paroxetine, Fluoxetine, Fluoxetine, Fluoxetine, Fluoxetine, and others. In contrast, counseling involves talk therapy with therapists or psychologists who provide management tips to help combat the conditions.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Key Management Market Dynamics Postpartum Depression?
The growing demand for antidepressant drugs and talk therapies by expectant pregnant mothers is projecting the growth of the postpartum depression management market. Therefore, spending on postpartum depression management is increasing over time.
The postpartum depression management market is growing worldwide as women across the globe are lately experiencing postpartum depression as they find it difficult to cope with new responsibilities. The postpartum depression management market includes various home remedies that involve maintaining healthy lifestyle choices, avoiding isolation, to set realistic expectations.
Based on treatment type, anti-depressants are the most commonly used treatment methods over therapies as anti-depressants provide fast treatment and promising results in less time as compared with psychotherapies.
The anti-depressants treatment segment thus accounts for the largest revenue share in the postpartum depression management market. The segment is anticipated to follow the same trend in the postpartum depression management market over the next few years. As a result, women prefer it over psychotherapies to achieve faster results.
Some of the key factors driving the growth of the postpartum depression management market include the rise in risk factors associated with postpartum depression. These include the growing preference of women for the treatment of postpartum depression.
Women have become more aware of postpartum depression management and are more inclined to seek early treatment and therapies, which is further driving the global market for postpartum depression management.
It is expected that postpartum depression management market growth will be constrained by negligence and unacceptance of the condition, along with an inability to detect depression.
Regional Analysis
How is the North America Postpartum Depression Management Market Evolving?
The demand for postpartum depression management has increased in the North American region. North America is anticipated to control a postpartum depression management market share of 37.5% in 2022.
In the last decade, North America has held the largest revenue share in the global postpartum depression management market on account of rising awareness among women regarding postpartum depression. It also enhanced decision-making by women with high educational attainment and easy availability of psychotherapy sessions with specialized doctors.
What is the Growth Outlook for the Europe Postpartum Depression Management Market?
Europe's Postpartum Depression Management is predicted to experience significant growth and hold a market share of 29% in 2022. Mental health awareness is increasing among individuals and major companies are investing in countries in this region, which is driving revenues in the Europe postpartum depression market.
The market for postpartum depression in Europe is expected to be driven by an increasing number of initiatives to treat postpartum depression through telemedicine virtual support over calls and online counseling, as well as an increasing number of support groups and mental health communities for mothers.
Find your sweet spots for generating winning opportunities in this market.
Start-up Ecosystem
How is the Start-up Ecosystem in the Postpartum Depression Management Market?
The start-up ecosystem in the postpartum depression management market is clouded by several pharmaceutical companies, including Marinus Pharma and others, who are actively developing therapies to grow the postpartum depression management market share. In addition, they manufacture novel therapies to transform the treatment paradigm of the postpartum depression management market.
Sage Therapeutics and Marinus Pharmaceuticals are two major players developing therapies for postpartum depression (PPD). There will be a significant impact on the postpartum depression (PPD) market from the launch of new therapies such as SAGE-217 and Ganaxolone.
The American biopharmaceutical firm Sage Therapeutics, which developed Zuranolone with Biogen Inc., announced on 1 June 2022 that it had achieved all primary and secondary endpoints in its Phase 3 SKYLARK study.
How is Competition Landscape in the Postpartum Depression Management Market?
The postpartum depression management market is consolidated with a presence of a few strong players from around the globe. Some of the key players present in the global postpartum depression management market are Sage Therapeutics Inc., Cipla Limited, Sun Pharmaceutical Industries Ltd., Anikem Laboratories, Intas Pharmaceuticals Ltd., Mylan N.V., Sumika Fine Chemicals Co Ltd., and others.
emerging trends in the postpartum depression management market are brought about as a result of the major players' adoption of several growth strategies, including product launches, acquisitions, and collaborations.
Some of the recent developments in the Postpartum Depression Management market are as follows:
A leading player among two prominent emerging players is Sage Therapeutics with its drug prospect SAGE-217 which has been shown in clinical trials to show promise in battling postpartum depression.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Report Scope
Report Attribute
Details
Growth Rate
CAGR of 3.8% from 2022 to 2032
Base Year for Estimation
2022
Historical Data
2016 to 2021
Forecast Period
2022 to 2032
Quantitative Units
Revenue in USD Million and CAGR from 2022 to 2032
Report Coverage
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
Treatment Type
Distribution Channel
Region
Regions Covered
North America
Latin America
Western Europe
Eastern Europe
The Asia Pacific excluding Japan
Japan
The Middle East and Africa
Key Countries Profiled
The USA
Canada
Brazil
Argentina
Germany
The UK
France
Spain
Italy
Nordics
BENELUX
Australia & New Zealand
China
India
GCC Countries
South Africa
Key Companies Profiled
Sage Therapeutics Inc.
Cipla Limited
Sun Pharmaceutical Industries Ltd.
Anikem Laboratories
Intas Pharmaceuticals Ltd.
Mylan N.V.
Sumika Fine Chemicals Co Ltd.
Customization
Available Upon Request
Key Segments
By Treatment Type:
Anti-Depressant Drugs
Bupropion
Fluoxetine
Doxepin
Others
By Distribution Channel:
Hospital
Retail
Drug Stores
E-Commerce
By Region:
North America
Latin America
Middle East and Africa
Europe
Asia Pacific
Frequently Asked Questions
What is the Future of the Postpartum Depression Management Market?
The postpartum depression management market is likely to account for US$ 173.9 million by 2032.
What is the Anticipated Postpartum Depression Management Market Share of North America?
North America is likely to hold a postpartum depression management market share of 37.5% in 2022.
What is the Growth Outlook for the Postpartum Depression Management Market?
The global postpartum depression management market is set to advance at a CAGR of 3.8% from 2022 to 2032.
What is the Size of Postpartum Depression Management?
The postpartum depression management market is projected to grow to US$ 115.1 million in 2022.
Table of Content
1. Executive Summary | Postpartum Depression Management Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Treatment
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Treatment, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment, 2022 to 2032
5.3.1. Anti-Depressant Drugs
5.3.2. New Anti-Depressant Drugs
5.3.3. SAGE-547
5.3.4. Bupropion
5.3.5. Escitalopram
5.3.6. Fluoxetine
5.3.7. Paroxetine
5.3.8. Sertraline
5.3.9. Old Anti-Depressant Drugs
5.3.10. Amitriptyline
5.3.11. Desipramine
5.3.12. Others
5.4. Y-o-Y Growth Trend Analysis By Treatment, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Treatment, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2022 to 2032
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Drug Stores
6.3.4. E-commerce
6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. United States of America
8.2.1.2. Canada
8.2.2. By Treatment
8.2.3. By Distribution Channel
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Treatment
8.3.3. By Distribution Channel
8.4. Key Takeaways
9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Treatment
9.2.3. By Distribution Channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Treatment
9.3.3. By Distribution Channel
9.4. Key Takeaways
10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Treatment
10.2.3. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Treatment
10.3.3. By Distribution Channel
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. India
11.2.1.5. Malaysia
11.2.1.6. Singapore
11.2.1.7. Australia
11.2.1.8. New Zealand
11.2.1.9. Rest of Asia-Pacific
11.2.2. By Treatment
11.2.3. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Treatment
11.3.3. By Distribution Channel
11.4. Key Takeaways
12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of Middle East and Africa
12.2.2. By Treatment
12.2.3. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Treatment
12.3.3. By Distribution Channel
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. United States of America
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Treatment
13.1.2.2. By Distribution Channel
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Treatment
13.2.2.2. By Distribution Channel
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Treatment
13.3.2.2. By Distribution Channel
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Treatment
13.4.2.2. By Distribution Channel
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Treatment
13.5.2.2. By Distribution Channel
13.6. United Kingdom
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Treatment
13.6.2.2. By Distribution Channel
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Treatment
13.7.2.2. By Distribution Channel
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Treatment
13.8.2.2. By Distribution Channel
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Treatment
13.9.2.2. By Distribution Channel
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Treatment
13.10.2.2. By Distribution Channel
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Treatment
13.11.2.2. By Distribution Channel
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Treatment
13.12.2.2. By Distribution Channel
13.13. Malaysia
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Treatment
13.13.2.2. By Distribution Channel
13.14. Singapore
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Treatment
13.14.2.2. By Distribution Channel
13.15. Australia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Treatment
13.15.2.2. By Distribution Channel
13.16. New Zealand
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Treatment
13.16.2.2. By Distribution Channel
13.17. GCC Countries
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Treatment
13.17.2.2. By Distribution Channel
13.18. South Africa
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Treatment
13.18.2.2. By Distribution Channel
13.19. Israel
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Treatment
13.19.2.2. By Distribution Channel
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Treatment
14.3.3. By Distribution Channel
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. SAGE Therapeutics Inc.
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Cipla Limited
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Sun Pharmaceutical Industries Ltd.
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Anikem Laboratories
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Intas Pharmaceuticals Ltd.
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Mylan N.V.
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Sumika Fine Chemicals Co Ltd.
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Aurobindo Pharma
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Lupin
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. Accord Healthcare
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
16. Assumptions & Acronyms Used17. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032
Table 2: Global Market Value (US$ Million) Forecast by Treatment, 2017 to 2032
Table 3: Global Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2032
Table 4: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 5: North America Market Value (US$ Million) Forecast by Treatment, 2017 to 2032
Table 6: North America Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2032
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 8: Latin America Market Value (US$ Million) Forecast by Treatment, 2017 to 2032
Table 9: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2032
Table 10: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 11: Europe Market Value (US$ Million) Forecast by Treatment, 2017 to 2032
Table 12: Europe Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2032
Table 13: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 14: Asia Pacific Market Value (US$ Million) Forecast by Treatment, 2017 to 2032
Table 15: Asia Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2032
Table 16: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 17: Middle East and Africa Market Value (US$ Million) Forecast by Treatment, 2017 to 2032
Table 18: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Treatment, 2022 to 2032
Figure 2: Global Market Value (US$ Million) by Distribution Channel, 2022 to 2032
Figure 3: Global Market Value (US$ Million) by Region, 2022 to 2032
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 7: Global Market Value (US$ Million) Analysis by Treatment, 2017 to 2032
Figure 8: Global Market Value Share (%) and BPS Analysis by Treatment, 2022 to 2032
Figure 9: Global Market Y-o-Y Growth (%) Projections by Treatment, 2022 to 2032
Figure 10: Global Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2032
Figure 11: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 12: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 13: Global Market Attractiveness by Treatment, 2022 to 2032
Figure 14: Global Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 15: Global Market Attractiveness by Region, 2022 to 2032
Figure 16: North America Market Value (US$ Million) by Treatment, 2022 to 2032
Figure 17: North America Market Value (US$ Million) by Distribution Channel, 2022 to 2032
Figure 18: North America Market Value (US$ Million) by Country, 2022 to 2032
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 22: North America Market Value (US$ Million) Analysis by Treatment, 2017 to 2032
Figure 23: North America Market Value Share (%) and BPS Analysis by Treatment, 2022 to 2032
Figure 24: North America Market Y-o-Y Growth (%) Projections by Treatment, 2022 to 2032
Figure 25: North America Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2032
Figure 26: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 28: North America Market Attractiveness by Treatment, 2022 to 2032
Figure 29: North America Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 30: North America Market Attractiveness by Country, 2022 to 2032
Figure 31: Latin America Market Value (US$ Million) by Treatment, 2022 to 2032
Figure 32: Latin America Market Value (US$ Million) by Distribution Channel, 2022 to 2032
Figure 33: Latin America Market Value (US$ Million) by Country, 2022 to 2032
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 37: Latin America Market Value (US$ Million) Analysis by Treatment, 2017 to 2032
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2022 to 2032
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2022 to 2032
Figure 40: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2032
Figure 41: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 43: Latin America Market Attractiveness by Treatment, 2022 to 2032
Figure 44: Latin America Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 45: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 46: Europe Market Value (US$ Million) by Treatment, 2022 to 2032
Figure 47: Europe Market Value (US$ Million) by Distribution Channel, 2022 to 2032
Figure 48: Europe Market Value (US$ Million) by Country, 2022 to 2032
Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 52: Europe Market Value (US$ Million) Analysis by Treatment, 2017 to 2032
Figure 53: Europe Market Value Share (%) and BPS Analysis by Treatment, 2022 to 2032
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Treatment, 2022 to 2032
Figure 55: Europe Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2032
Figure 56: Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 57: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 58: Europe Market Attractiveness by Treatment, 2022 to 2032
Figure 59: Europe Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 60: Europe Market Attractiveness by Country, 2022 to 2032
Figure 61: Asia Pacific Market Value (US$ Million) by Treatment, 2022 to 2032
Figure 62: Asia Pacific Market Value (US$ Million) by Distribution Channel, 2022 to 2032
Figure 63: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032
Figure 64: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 67: Asia Pacific Market Value (US$ Million) Analysis by Treatment, 2017 to 2032
Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Treatment, 2022 to 2032
Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Treatment, 2022 to 2032
Figure 70: Asia Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2032
Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 73: Asia Pacific Market Attractiveness by Treatment, 2022 to 2032
Figure 74: Asia Pacific Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 75: Asia Pacific Market Attractiveness by Country, 2022 to 2032
Figure 76: Middle East and Africa Market Value (US$ Million) by Treatment, 2022 to 2032
Figure 77: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2022 to 2032
Figure 78: Middle East and Africa Market Value (US$ Million) by Country, 2022 to 2032
Figure 79: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 80: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 81: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 82: Middle East and Africa Market Value (US$ Million) Analysis by Treatment, 2017 to 2032
Figure 83: Middle East and Africa Market Value Share (%) and BPS Analysis by Treatment, 2022 to 2032
Figure 84: Middle East and Africa Market Y-o-Y Growth (%) Projections by Treatment, 2022 to 2032
Figure 85: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2032
Figure 86: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 87: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 88: Middle East and Africa Market Attractiveness by Treatment, 2022 to 2032
Figure 89: Middle East and Africa Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 90: Middle East and Africa Market Attractiveness by Country, 2022 to 2032
